Fig. 2From: The effects of the administration sequence and the type of hypnotics on the development of remifentanil-induced chest wall rigidity: a randomized controlled trialThe number of patients experiencing chest wall rigidity according to the administration sequence of the hypnotics and remifentanil as well as the type of hypnotic. *The numbers of patients who exhibited chest wall rigidity were 13/60 (21.7%) and 33/60 (55.0%) in the hypnotic-remifentanil and remifentanil-hypnotic groups, respectively (P < 0.001). There was no significant difference in the development of chest wall rigidity between propofol and thiopental sodium useBack to article page